Altered lipid metabolism has been associated to cystic fibrosis disease, which is characterized by chronic lung inflammation and various organs dysfunction. Here, we present the validation of an untargeted lipidomics approach based on high-resolution mass spectrometry aimed at identifying those lipid species that unequivocally sign CF pathophysiology. Of n.13375 mass spectra recorded on cystic fibrosis bronchial epithelial airways epithelial cells IB3, n.7787 presented the MS/MS data, and, after software and manual validation, the final number of annotated lipids was restricted to n.1159. On these lipids, univariate and multivariate statistical approaches were employed in order to select relevant lipids for cellular phenotype discrimination between cystic fibrosis and HBE healthy cells. In cystic fibrosis IB3 cells, a pervasive alteration in the lipid metabolism revealed changes in the classes of ether-linked phospholipids, cholesterol esters, and glycosylated sphingolipids. Through functions association, it was evidenced that lipids variation involves the moiety implicated in membrane composition, endoplasmic reticulum, mitochondria compartments, and chemical and biophysical lipids properties. This study provides a new perspective in understanding the pathogenesis of cystic fibrosis and strengthens the need to use a validated mass spectrometry-based lipidomics approach for the discovery of potential biomarkers and perturbed metabolism.
An Innovative Lipidomic Workflow to Investigate the Lipid Profile in a Cystic Fibrosis Cell Line / M. Dei Cas, A. Zulueta, A. Mingione, A. Caretti, R. Ghidoni, P. Signorelli, R. Paroni. - In: CELLS. - ISSN 2073-4409. - 9:5(2020 May 12).
|Titolo:||An Innovative Lipidomic Workflow to Investigate the Lipid Profile in a Cystic Fibrosis Cell Line|
DEI CAS, MICHELE VITTORIO (Primo) (Corresponding)
ZULUETA MORALES, AIDA (Secondo)
SIGNORELLI, PAOLA (Penultimo)
PARONI, RITA CLARA (Ultimo)
|Parole Chiave:||OMICS; biomarker; cell structure; cystic fibrosis; lipidomics; membrane composition; sphingolipid; untargeted analysis|
|Settore Scientifico Disciplinare:||Settore BIO/10 - Biochimica|
Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica
|Data di pubblicazione:||12-mag-2020|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.3390/cells9051197|
|Appare nelle tipologie:||01 - Articolo su periodico|